CoChat

Clinical perspectives on the age-related increase of immunosuppressive activity

Open access
Salminen, Antero · 2022 · Journal of Molecular Medicine

The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.

Abstract

The aging process is associated with a remodeling of the immune system involving chronic low-grade inflammation and a gradual decline in the function of the immune system. These processes are also called inflammaging and immunosenescence. The age-related immune remodeling is associated with many clinical changes, e.g., risk for cancers and chronic infections increases, whereas the efficiency of vaccination and immunotherapy declines with aging. On the other hand, there is convincing evidence that chronic inflammatory states promote the premature aging process. The inflammation associated with aging or chronic inflammatory conditions stimulates a counteracting immunosuppression which protects tissues from excessive inflammatory injuries but promotes immunosenescence. Immunosuppression is a driving force in tumors and chronic infections and it also induces the tolerance to vaccination and immunotherapies. Immunosuppressive cells, e.g., myeloid-derived suppressor cells (MDSC), regulatory T cells (Treg), and type M2 macrophages, have a crucial role in tumorigenesis and chronic infections as well as in the tolerance to vaccination and immunotherapies. Interestingly, there is substantial evidence that inflammaging is also associated with an increased immunosuppressive activity, e.g., upregulation of immunosuppressive cells and anti-inflammatory cytokines. Given that both the aging and chronic inflammatory states involve the activation of immunosuppression and immunosenescence, this might explain why aging is a risk factor for tumorigenesis and chronic inflammatory states and conversely, chronic inflammatory insults promote the premature aging process in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00109-022-02193-4

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Inflammaging and chronic inflammatory conditions remodel the immune system by inducing a counteracting immunosuppression which promotes immunosenescence. The immunosuppressive network involves MDSCs, Tregs, Bregs, DCregs, NKregs, NKT II cells, and type M2 macrophages. Subsequently, immunosuppression and an inefficient immune system disturb the efficacy of immune responses which increase the risk for cancers and chronic infections as well as decreasing the efficiency of vaccination and immunotherapy. Conversely, the increased immunosuppression associated with aging enhances transplantation tolerance. Abbreviation: Breg, regulatory B cell; DCreg, regulatory dendritic cell; MDSC, myeloid-derived suppressor cell; NKreg, regulatory natural killer cell; NKT II, type II natural killer T cell; Treg, regulatory T cell
Fig. 1 Inflammaging and chronic inflammatory conditions remodel the immune system by inducing a counteracting immunosuppression which promotes immunosenescence. The immunosuppressive network involves MDSCs, Tregs, Bregs, DCregs, NKregs, NKT II cells, and type M2 macrophages. Subsequently, immunosuppression and an inefficient immune system disturb the efficacy of immune responses which increase the risk for cancers and chronic infections as well as decreasing the efficiency of vaccination and immunotherapy. Conversely, the increased immunosuppression associated with aging enhances transplantation tolerance. Abbreviation: Breg, regulatory B cell; DCreg, regulatory dendritic cell; MDSC, myeloid-derived suppressor cell; NKreg, regulatory natural killer cell; NKT II, type II natural killer T cell; Treg, regulatory T cellCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 207 references

Cited by

See all 60

Metadata

Authors
Salminen, A.
Affiliations
University of Eastern Finland (FI)
Corresponding author
Salminen, Antero
Venue
Journal of Molecular Medicine
Published
2022-04-06
Volume
100
Issue
5
Pages
697-712
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W4225766275
Cited by
57
References
207
Citations by year
2026: 9 · 2025: 7 · 2024: 19 · 2023: 18 · 2022: 4
FWCI
1.26
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Molecular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • N/A
  • University of Eastern Finland (UEF) including Kuopio University Hospital
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
inflammaging, immunosenescence, immunosuppression, aging, chronic inflammation, myeloid-derived suppressor cells, regulatory T cells, M2 macrophages, anti-inflammatory cytokines, vaccine tolerance, carcinogenesis, chronic infection, premature aging
MeSH terms
Immunosenescence, Aging, Humans, Immunosuppressive Agents, Inflammation, Neoplasms, Aging, Premature, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical perspectives on the age-related increase of immunosuppressive activity. https://app.cochat.ai/papers/10.1007/s00109-022-02193-4
The paper
Salminen, A. (2022). Clinical perspectives on the age-related increase of immunosuppressive activity. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-022-02193-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.